|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Aphton Corporation (APHT) Announces Restructuring Of Long-Term Debt
11/10/2005 3:23:38 PM
PHILADELPHIA--(BUSINESS WIRE)--Nov. 9, 2005--Aphton Corporation (NASDAQ:APHT) announced today that the Company entered into a binding letter agreement with the holders of the Company's $20 million Senior Convertible Notes, which were issued to the holders in March and June of 2003. Under the terms of the letter agreement, the holders agree to surrender the Senior Convertible Notes for cancellation by the Company and exchange the entire principal balance of $20 million due under the notes for $3 million in cash, shares of the Company's newly issued 0% Non-participating Series A Convertible Preferred Stock with an original Stated Value of $10 million and 6,500,000 shares of the Company's common stock, of which 1,500,000 shares will be placed in escrow at closing to be released upon the occurrence of certain events. The parties anticipate closing the transaction on or prior to November 18, 2005.
|
|
|
|
|
|
|
|
|
|
|